Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Stamp

Showing results (11-20 of 323) with videos related to

Pageof 33
Sort By:
Expert Opinion on Biological Therapy|October 20, 2023
What future do biological therapies have in the treatment of gout?Lisa K Stamp, Angelo Gaffo
Nature Reviews. Rheumatology|July 8, 2015
Gout: Why compare the effectiveness of suboptimal gout management?Nicola Dalbeth, Lisa K Stamp
Seminars in Arthritis and Rheumatism|January 14, 2024
Moving urate-lowering therapy in gout beyond guideline recommendationsLisa K Stamp, Nicola Dalbeth
Alimentary Pharmacology & Therapeutics|January 18, 2018
Editorial: vedolizumab as a treatment and cause of extra-intestinal manifestations of inflammatory bowel diseaseM L Barclay, L K Stamp
Pharmacogenomics|April 17, 2015
Pharmacogenetic considerations in the treatment of goutRebecca L Roberts, Lisa K Stamp
Pharmacogenomics|October 20, 2011
Effect of genetic polymorphisms in the folate pathway on methotrexate therapy in rheumatic diseasesLisa K Stamp, Rebecca L Roberts
FEBS Letters|September 1, 1971
Complementary trimer binding to transfer RNA(Phe)O Pongs, E Reinwald, K Stamp
Drugs & Aging|September 27, 2014
Urate-lowering therapy: current options and future prospects for elderly patients with goutLisa K Stamp, Peter T Chapman
The Lancet. Rheumatology|January 31, 2024
Self-management of gout using a mobile appLisa K Stamp, Angelo L Gaffo
Rheumatology (Oxford, England)|December 23, 2017
How to prevent allopurinol hypersensitivity reactions?Lisa K Stamp, Murray L Barclay
Pageof 33

Showing results (11-20 of 323) with videos related to

Sort By:
Pageof 33
Expert Opinion on Biological Therapy|October 20, 2023
What future do biological therapies have in the treatment of gout?Lisa K Stamp, Angelo Gaffo
Nature Reviews. Rheumatology|July 8, 2015
Gout: Why compare the effectiveness of suboptimal gout management?Nicola Dalbeth, Lisa K Stamp
Seminars in Arthritis and Rheumatism|January 14, 2024
Moving urate-lowering therapy in gout beyond guideline recommendationsLisa K Stamp, Nicola Dalbeth
Alimentary Pharmacology & Therapeutics|January 18, 2018
Editorial: vedolizumab as a treatment and cause of extra-intestinal manifestations of inflammatory bowel diseaseM L Barclay, L K Stamp
Pharmacogenomics|April 17, 2015
Pharmacogenetic considerations in the treatment of goutRebecca L Roberts, Lisa K Stamp
Pharmacogenomics|October 20, 2011
Effect of genetic polymorphisms in the folate pathway on methotrexate therapy in rheumatic diseasesLisa K Stamp, Rebecca L Roberts
FEBS Letters|September 1, 1971
Complementary trimer binding to transfer RNA(Phe)O Pongs, E Reinwald, K Stamp
Drugs & Aging|September 27, 2014
Urate-lowering therapy: current options and future prospects for elderly patients with goutLisa K Stamp, Peter T Chapman
The Lancet. Rheumatology|January 31, 2024
Self-management of gout using a mobile appLisa K Stamp, Angelo L Gaffo
Rheumatology (Oxford, England)|December 23, 2017
How to prevent allopurinol hypersensitivity reactions?Lisa K Stamp, Murray L Barclay
Pageof 33